Hutch News
Results per Page:
Does CAR T-cell therapy leave patients vulnerable to infection?
$3.3M Cancer Moonshot grant to study how immunotherapy impacts patients’ ability to fight off bugs
HIV vaccine trial uncovers plausible mechanisms of protection
From the HVTN, Vaccine and Infectious Disease Division
Engineering B cells to bypass vaccines
From the Taylor Lab, Vaccine and Infectious Disease Division
Engineering vaccine-like protection without a vaccine
CRISPR gene-editing used on antibody-making B cells
Cancer cells BiTE the dust through SMITE-bispecific mediated T cell activation
- from the Walter's and Mehlin's labs, Clinical Research Division
New antibody and unique binding site offer possible paths to malaria prevention
Led by NIH, Fred Hutch researchers, early study holds promise for direct infusion or vaccine design
Bringing a leukemia treatment back to life with precision medicine
New research writes latest chapter in one drug's story
Deciphering how influenza escapes neutralizing antibodies
From the Bloom Laboratory, Basic Sciences Division
Good News: $475K gift fuels expansion of antibody tech; Hansen honored for BMT work; Senate passes 21st Century Cures Act
Celebrating faculty and staff achievements
Good News: Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response
Celebrating faculty and staff achievements
Good News at Fred Hutch: Immunotherapy pioneer named chair, Nobel laureate keynotes
Celebrating faculty and staff achievements
Good News at Fred Hutch
Dr. Roland Walter receives two grant awards for acute leukemia research; Dr. Jonathan Bricker to keynote behavioral therapy conference; Dr. Benjamin Anderson chairs NCCN committee that publishes clinical-practice guidelines for cervical cancer
HIV cure research today: Gene therapy, molecular scissors and Where’s Waldo
More than 100 researchers gather at second annual Fred Hutch conference
Gut microbiome may have interfered with experimental HIV vaccines
Inoculating infants instead of adults could bypass problem, researchers say